The potential of interferons in malignant disease

Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective study.

ESMO real world data and digital oncology·2026

Patient-related risk factors for outlet obstruction in diverting loop ileostomy following minimally invasive rectal cancer surgery.

Techniques in coloproctology·2025

PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2019

Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.

Molecular psychiatry·2017

Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.

Molecular psychiatry·2016

Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.

Journal of dental research·2015

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation.

Drugs·2026

Lunsotogene Parvec: First Approval.

Drugs·2026

Acoziborole: First Approval.

Drugs·2026

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Drugs·2026

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.

Drugs·2026

Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus.

Drugs·2026

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Cancer research·2026

Synchronous Papillary Thyroid Carcinoma and an Angiomatoid Fibrous Histiocytoma: A Rare, Interesting Case Report.

Cureus·2026

Hyalinizing Trabecular Tumor of the Thyroid Gland: A Diagnostic and Surgical Challenge.

Cureus·2026

Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.

Frontiers in immunology·2026

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.

Frontiers in immunology·2026

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Cancer cell·2026

Related Experiment Videos

The potential of interferons in malignant disease

Related Concept Videos

Real-world safety and efficacy of enzalutamide versus darolutamide in nonmetastatic castration-resistant prostate cancer: a multicenter retrospective study.

Patient-related risk factors for outlet obstruction in diverting loop ileostomy following minimally invasive rectal cancer surgery.

PRDM14 promotes malignant phenotype and correlates with poor prognosis in colorectal cancer.

Striatal dopamine D1-type receptor availability: no difference from control but association with cortical thickness in methamphetamine users.

Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.

Gingival Fibroblasts as Autologous Feeders for Induced Pluripotent Stem Cells.

Small-Cell Lung Cancer: Biology, Translational Science and Clinical Innovation.

Lunsotogene Parvec: First Approval.

Acoziborole: First Approval.

DLL3-Targeted Strategies in Advanced Prostate Cancer: Current Evidence and Future Perspectives.

Emerging Strategies Targeting the PI3K/AKT/mTOR Pathway in HR+/HER2- Advanced Breast Cancer.

Balancing Act: The Dual Roles of BAFF in Systemic Lupus Erythematosus.

Immune Circuit Rewiring by HDAC Inhibition Enables Response to Dual Checkpoint Blockade in Metastatic Breast Cancer.

Synchronous Papillary Thyroid Carcinoma and an Angiomatoid Fibrous Histiocytoma: A Rare, Interesting Case Report.

Hyalinizing Trabecular Tumor of the Thyroid Gland: A Diagnostic and Surgical Challenge.

Neural regulation of immune evasion in breast cancer: a multiscale neuro-immune framework.

Beyond exhaustion: T cell fitness for next generation of immunotherapy for hematological cancer.

Latent effector T cells mediate immunotherapy responses in the bone marrow microenvironment.

Related Experiment Videos

The potential of interferons in malignant disease

Related Concept Videos

Related Articles